Aemetis Inc (AMTX):企業の財務・戦略的SWOT分析

◆英語タイトル:Aemetis Inc (AMTX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDAE10320FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Alternative Energy
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aemetis Inc (Aemetis) formerly AE Biofuels Inc is a renewable fuels and biochemicals company that produces advanced fuels and chemicals. The company’s products include biochemicals, renewable fuels, ethanol, ethanol co-products, glycerin, biodiesel, and edible oils, among others. It also provides products for human and animal consumption. Aemetis produces distillers grains for California’s Central Valley cattle industry and palm olein. The company operates through its research and development, and production facilities in India and the US. It markets its products through distributors, resellers, refiners directly and a network of independent sales agents. Aemetis is headquartered in Cupertino, California, the US.

Aemetis Inc Key Recent Developments

Mar 17,2021: Aemetis receives approval for 32 mile extension of biogas pipeline for dairy RNG Project
Mar 16,2021: Aemetis India renewable fuels plant selected for $3 Million per month supply of biodiesel to Andhra Pradesh state road transport
Mar 12,2021: Aemetis CEO Eric McAfee to Present at the 33rdRoth Capital Conference on March 15-17, 2021
Mar 09,2021: Aemetis to Review Fourth Quarter and Year-End Financial Results on March 11 2021
Feb 04,2021: Koch Project Solutions to execute Aemetis carbon zero renewable jet and diesel projects

This comprehensive SWOT profile of Aemetis Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Aemetis Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Aemetis Inc – Key Information
Aemetis Inc – Overview
Aemetis Inc – Key Employees
Aemetis Inc – Key Employee Biographies
Aemetis Inc – Key Operational Heads
Aemetis Inc – Major Products and Services
Aemetis Inc – History
Aemetis Inc – Company Statement
Aemetis Inc – Locations And Subsidiaries

Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Aemetis Inc – Business Description
Aemetis Inc – Corporate Strategy
Aemetis Inc – SWOT Analysis
SWOT Analysis – Overview
Aemetis Inc – Strengths
Aemetis Inc – Weaknesses
Aemetis Inc – Opportunities
Aemetis Inc – Threats
Aemetis Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Aemetis Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Aemetis Inc, Key Information
Aemetis Inc, Key Ratios
Aemetis Inc, Share Data
Aemetis Inc, Major Products and Services
Aemetis Inc, History
Aemetis Inc, Key Employees
Aemetis Inc, Key Employee Biographies
Aemetis Inc, Key Operational Heads
Aemetis Inc, Other Locations
Aemetis Inc, Subsidiaries

Aemetis Inc, Key Competitors
Aemetis Inc, SWOT Analysis
Aemetis Inc, Ratios based on current share price
Aemetis Inc, Annual Ratios
Aemetis Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Aemetis Inc (AMTX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IsoRay Inc (ISR):医療機器:M&Aディール及び事業提携情報
    Summary IsoRay Inc (IsoRay), formerly Century Park Pictures Corporation, is a medical technology company which develops, manufactures and markets isotope-based personalized brachytherapy products and devices for the treatment of cancer and other malignant tumors. The company produced Cesium-131, a r …
  • Isofol Medical AB (ISOFOL)-製薬・医療分野:企業M&A・提携分析
    Summary Isofol Medical AB (Isofol) is a clinical stage pharmaceutical company developing folate-based therapies for the treatment of cancer patients. The company’s clinical lead candidate Modufolin, a metabolite is under clinical phase I/II development being evaluated for the treatment of colorectal …
  • Angelo Iafrate Construction Company:企業の戦略・SWOT・財務分析
    Angelo Iafrate Construction Company - Strategy, SWOT and Corporate Finance Report Summary Angelo Iafrate Construction Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Royal DSM NV (DSM):企業の財務・戦略的SWOT分析
    Royal DSM NV (DSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Impinj Inc (PI):企業の財務・戦略的SWOT分析
    Impinj Inc (PI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Manila Electric Company:企業の戦略・SWOT・財務情報
    Manila Electric Company - Strategy, SWOT and Corporate Finance Report Summary Manila Electric Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Capstone Turbine Corp (CPST):企業の財務・戦略的SWOT分析
    Capstone Turbine Corp (CPST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Auspex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Auspex Pharmaceuticals Inc (Auspex), a subsidiary of Teva Pharmaceutical Industries Ltd is a biopharmaceutical company that develops and commercializes novel medicines for the treatment of movement disorders and other rare diseases including orphan diseases. The company offers products for t …
  • Macy’s Inc:企業の戦略・SWOT・財務情報
    Macy's Inc - Strategy, SWOT and Corporate Finance Report Summary Macy's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Shell Pakistan Ltd (SHEL):企業の財務・戦略的SWOT分析
    Summary Shell Pakistan Ltd (Shell Pakistan), a subsidiary of Royal Dutch Shell plc is an oil and gas company that markets petroleum products and compressed natural gas. The company operates through three segments such as retail, lubricants and aviation. It retail segment offers a range of fuels such …
  • U.S. Stem Cell Inc (USRM):医療機器:M&Aディール及び事業提携情報
    Summary U.S. Stem Cell Inc (U.S. Stem Cell), formerly Bioheart, Inc, is a biotechnology company that focuses on the discovery, development and commercialization of cell based therapeutics products. The company repairs and replaces damaged or aged tissue, cells and organs and restoring their normal f …
  • Hirose Electric Co Ltd (6806):企業の財務・戦略的SWOT分析
    Hirose Electric Co Ltd (6806) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Covance Inc:医療機器:M&Aディール及び事業提携情報
    Summary Covance Inc (Covance), a subsidiary of LabCorp, is a drug development company that offers contract research and manufacturing services. The company offers a broad range of early-stage and late-stage product development services to pharmaceutical, biotechnology and medical device companies. I …
  • EQT Corporation:企業の戦略・SWOT・財務情報
    EQT Corporation - Strategy, SWOT and Corporate Finance Report Summary EQT Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Nongshim Co. Ltd.:企業の戦略・SWOT・財務情報
    Nongshim Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nongshim Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Semiconductor Manufacturing International Corporation:企業のM&A・事業提携・投資動向
    Semiconductor Manufacturing International Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Semiconductor Manufacturing International Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes busin …
  • Bionik Laboratories Corp (BNKL):企業の財務・戦略的SWOT分析
    Summary Bionik Laboratories Corp (Bionik) is a medical device company that designs and develops transformational technologies, prosthetics and assisted robotic products and solutions. The company offers rehabilitation technology that senses patient movements and limitations. It provides lower body e …
  • Natera Inc (NTRA):企業の製品パイプライン分析2018
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …
  • CohBar Inc (COB.U):企業の財務・戦略的SWOT分析
    Summary CohBar Inc (CohBar) is a developer of mitochondria based therapeutics. The company develops a class of drugs to treat a wide range of diseases associated with aging and metabolic dysfunction such as non-alcoholic steatohepatitis, obesity, type 2 diabetes, cancer, cardiovascular disease and C …
  • MannKind Corp (MNKD):企業の財務・戦略的SWOT分析
    MannKind Corp (MNKD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆